About
Patrick Enright is a co-founder and managing director of Longitude Capital, a healthcare venture capital firm focused on biotechnology, medical technology, and health solutions. Before Longitude, he was a managing director at Pequot Ventures and earlier held investment and operating roles spanning Delta Opportunity Fund, PaineWebber Development Corporation, Roche, Novartis, and Valentis. He also serves on a broad set of healthcare company boards, including BioAge Labs, Zenas BioPharma, Vera Therapeutics, Jazz Pharmaceuticals, Epirium Bio, and Veradermics.
Areas of interest
biotechhealthcaremedical technologylongevitymetabolic diseaseobesity therapeuticsoncologyautoimmune diseasefibrosisneurodegenerationdermatologylife sciences investing